May
1
11:30 AM11:30

Virtual Roundtable: To Share, or Not to Share? That is the Question.

A Collaborative Event with our Alliance Partner, Westchester Biotech Project.

In this session, we cover the things companies and entrepreneurs fear most about sharing their ideas.

Description:

When starting a company, startup founders are not very willing to share information about their technology with others until they can secure legal patents and begin production/marketing. Their reluctance, in turn, results in less cross-pollination of ideas amongst the different companies within a given incubator, and willingness to share the scientific equipment.

Speakers will address which aspects of your intellectual property you should or should not share with others. We will discuss how to maintain good collaboration and communication, while limiting issues that could pose problems for your company or idea.

Who should attend: Entrepreneurs and early-stage companies who are the residents of shared co-working spaces such as incubators accelerators, etc. Academic and industry researchers considering starting their own companies. Co-working space managers.

Panelists:

photo 11-17.jpg

Alexander Margulis, PhD, Chief Operating Officer, Mansfield Bio-Incubator

Dr. Margulis is currently leveraging his scientific and business acumen in operation and business development. As a Chief Operating Officer at Mansfield Bio-Incubator, he is establishing a robust Life Science cluster in the Southeastern MA/RI. He achieved in a 90% occupancy within a year, in an underserved area of MA. In addition, he increased sales by 200% within two years within the US and Canada and placing the Capital Equipment instruments into world-class academic and Biotech/Pharma accounts in the Boston Area. He is trained as a Cellular and Molecular Biologist where his accomplishments include 12 authored scientific papers and numerous abstracts.

Gilles Bolduc.jpg

Gilles Bolduc, PhD, Professor in Biology, Massasoit Community College, Advisory Board Member, Mansfield Bio-Incubator

Dr. Bolduc is Director of Massasioit Community College's Biotechnology Certificate Program and Professor in Biology at Massasoit.  As Director, he designed the program and a new state-of-the-art biotechnology laboratory space.  He was awarded grants that supplied the lab with the latest equipment and which support an undergraduate research program.  Prior to coming to Massasoit, Dr. Bolduc was CMC Team Leader at Cequent Pharmaceuticals, Inc and is co-inventor of a U.S. and international patent based on Cequent's lead biologic.

Scott+Locke.jpg

Scott D. Locke, Esq., Partner & Chair Intellectual Property Department, Dorf & Nelson

Scott Locke counsels clients on the procurement, enforcement, and licensing of patents, trademarks, copyrights, and trade secrets. He provides solo inventors, start-up businesses, and well-established companies across diverse industries with strategies and tools for maximizing the return on their investment in their ingenuity, creativity, and goodwill. His clients include innovators in the fields of pharmaceuticals, delivery systems, diagnostics, siRNA technologies, Cas9 related technologies, gene therapies, and medical devices.

Additional speakers will be announced soon!

About the Mansfield BIO-Incubator:

Mansfield Bio-Incubator is a non-profit biotech, pharma, life science, and medical device business incubator facility. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech, pharma, life science, and medical device companies.  We were created to nurture entrepreneurial and economic development in the community. We aim to do this by maintaining affordable lab and office space and making cutting-edge technology, services, training, mentoring, and a network of professional advisors available to small biotechnology companies and healthcare-related start-ups.

About the Westchester Biotech Project:

The Westchester Biotech Project brings together researchers, engineers, and data scientists from across therapeutics, diagnostics, and devices. Based in Westchester County, NY, this is a borderless initiative with opportunities for local, national, and international collaboration. 

View Event →
May
29
11:30 AM11:30

Mastering the Business of Life Science

Mansfield Bio-Incubator new logo.jpg

Description:

As a highly educated science expert, you’re developing the next best medical breakthrough. Yet, if you don’t spend time raising money, managing that money, developing a commercialization plan and thinking about global markets, you will fail in the long run. Thinking about the business side of development can set you up for success long term. Come hear a panel of experts speak on successfully creating a vision and plan to master the business side of the science. Learn about:

  • Understanding the key components of a practical strategic plan

  • Performing the right business due diligence to align with your science

  • Creating a personalize success path

  • Raising the right money at the right time

  • Dodging painful mistakes

Who should attend: Early-stage entrepreneurs, investors, and business development professionals in life sciences.

 

Panelists:

Kristin King, Member/Investor Boston Harbor Angels    Kristin King  is an experienced biotech exec, serial intrapreneur, investor and strategic advisor to startups developing biotech solutions. Starting her career designing stents, a patent inventor for JnJ’s drug eluting stent, and progressing through marketing, strategic, and commercial leadership roles she has contributed to some of the world’s most meaningful programs at top biotech firms including Ansell Healthcare, Becton Dickinson, Johnson & Johnson, Abbott Vascular, and Pfizer. She has an MBA from NYU Stern in Marketing & Finance, and a BS in Bioengineering & Math from Syracuse. Kristin is a high energy leader, passionate about helping teams to advance healthcare solutions.

Kristin King, Member/Investor Boston Harbor Angels

Kristin King is an experienced biotech exec, serial intrapreneur, investor and strategic advisor to startups developing biotech solutions. Starting her career designing stents, a patent inventor for JnJ’s drug eluting stent, and progressing through marketing, strategic, and commercial leadership roles she has contributed to some of the world’s most meaningful programs at top biotech firms including Ansell Healthcare, Becton Dickinson, Johnson & Johnson, Abbott Vascular, and Pfizer. She has an MBA from NYU Stern in Marketing & Finance, and a BS in Bioengineering & Math from Syracuse. Kristin is a high energy leader, passionate about helping teams to advance healthcare solutions.

 
Jason Kraus, Venture Capital Investor; Startup Consultant and Advisor; Entrepreneur; 20k+ connections    Jason Kraus  serves as a partner in the EQx Fund, specializing in deal flow. He has experience in the venture arm of a private family office and as a member for the Boston Harbor Angels. Jason founded a startup advisory firm, Prepare 4 VC, to coach entrepreneurs through the fundraising process and create more powerful pitches. He is also a co-founder of commercial real estate and early stage investment firm Equity Venture Partners

Jason Kraus, Venture Capital Investor; Startup Consultant and Advisor; Entrepreneur; 20k+ connections

Jason Kraus serves as a partner in the EQx Fund, specializing in deal flow. He has experience in the venture arm of a private family office and as a member for the Boston Harbor Angels. Jason founded a startup advisory firm, Prepare 4 VC, to coach entrepreneurs through the fundraising process and create more powerful pitches. He is also a co-founder of commercial real estate and early stage investment firm Equity Venture Partners

 
Jack Malley, Partner at Rucci, Bardaro & Falzone, PC    Jack Malley  founded and was managing partner of Jensen & Malley Company, a Waltham-based business consulting firm formerly associated with Malley & Franey Financial Group, before the company was acquired by RBF in February 2016. As the partner in charge of RBF’s OASYS Group, he specializes in financial systems and operational consulting. He is an expert at assisting start-ups, investors, specialty lenders and established private and public companies in various stages of growth. Jack received his BA in economics from the College of the Holy Cross, and his MBA in accounting and finance from Northeastern University.

Jack Malley, Partner at Rucci, Bardaro & Falzone, PC

Jack Malley founded and was managing partner of Jensen & Malley Company, a Waltham-based business consulting firm formerly associated with Malley & Franey Financial Group, before the company was acquired by RBF in February 2016. As the partner in charge of RBF’s OASYS Group, he specializes in financial systems and operational consulting. He is an expert at assisting start-ups, investors, specialty lenders and established private and public companies in various stages of growth. Jack received his BA in economics from the College of the Holy Cross, and his MBA in accounting and finance from Northeastern University.

 
Tony Martignetti, Leadership Coach, Inspired Purpose Coaching    Tony Martignetti  is a leadership coach with a specialty in working with leaders and their teams to navigate through change and unlock their true potential. Tony supports leaders in gaining clarity so they can make better decisions, improve their leadership skills and ultimately increase their impact. Before sharing his experience as a coach, Tony was a finance and strategy professional with experience working with some of the world’s leading life sciences companies including Genzyme Corporation, Vertex Pharmaceuticals and Sarepta Therapeutics.

Tony Martignetti, Leadership Coach, Inspired Purpose Coaching

Tony Martignetti is a leadership coach with a specialty in working with leaders and their teams to navigate through change and unlock their true potential. Tony supports leaders in gaining clarity so they can make better decisions, improve their leadership skills and ultimately increase their impact. Before sharing his experience as a coach, Tony was a finance and strategy professional with experience working with some of the world’s leading life sciences companies including Genzyme Corporation, Vertex Pharmaceuticals and Sarepta Therapeutics.

 
Wendy Pease, President, Rapport International    Wendy Pease  is owner of Rapport International, a company that eliminates spoken and written language barriers around the world by offering written translation, spoken interpretation, transweblation, keyword and brand name testing, global communications consulting in 200+ languages. Prior to this, she served in corporate senior management positions in international marketing and business development, including roles at PAREXEL and Biogen. She has an MBA from Dartmouth College, and a BA in Foreign Service from Penn State. Wendy has lived in Mexico, Taiwan and the Philippines and is passionate about languages, cultures and communications.

Wendy Pease, President, Rapport International

Wendy Pease is owner of Rapport International, a company that eliminates spoken and written language barriers around the world by offering written translation, spoken interpretation, transweblation, keyword and brand name testing, global communications consulting in 200+ languages. Prior to this, she served in corporate senior management positions in international marketing and business development, including roles at PAREXEL and Biogen. She has an MBA from Dartmouth College, and a BA in Foreign Service from Penn State. Wendy has lived in Mexico, Taiwan and the Philippines and is passionate about languages, cultures and communications.

View Event →

Apr
2
11:30 AM11:30

Is Your Life Science Company: Ready to Scale Up and Grow? Operation Efficient?

Life science companies are about breakthrough ideas to change the world, but they also need to manage their costs, supply chains and timelines. The Lunch and Learn event will provide an opportunity to find out how MassMEP can help scale, manage growth and leverage all available resources.

View Event →
Mar
19
11:00 AM11:00

Our partner event: Are we truly ready for medical device interoperability?

vitalnow webinars.jpg

Are we truly ready for medical device interoperability?

Tuesday, March 19th,

11:00 - 11:30 am

Can't make it? Catch the replay here.

What you will learn:

  • Reasons for interoperability - vision for the future

  • Issues faced in making devices interoperable

  • Key emerging standards for device interoperability

  • How security needs to factor into interoperable systems

Who should attend:

  • Healthcare institution technical executives

  • Medical device executives and marketing managers

  • Medical device software designers / architects

Our guest speaker:

unnamed (2).jpg

Brian Shoemaker, Ph.D.

Principal Consultant

Brian Shoemaker consults for healthcare products companies in computer system validation, software quality assurance, and electronic records and signatures. He has conducted validation both on product software and on internal software, developed software quality systems, audited software quality processes (including agile methodology), and evaluated 21 CFR Part 11 compliance. He has had clients in clinical diagnostics, medical device engineering, medical imaging, medical-device fabrics manufacturing, contract lyophilization, clinical trial software, dental prosthetics, and bone-repair implants. He has worked with companies in Germany and Switzerland as well as the U.S.

Previous to founding ShoeBar Associates, Brian had quality roles at PPD Informatics, Doxis, Inc., and Behring Diagnostics, Inc. Brian earned his Ph.D. in chemistry from the University of Illinois; he has achieved the ASQ Software Quality Engineer certification.

shoebar associates.jpg
isaacson.jpg

Hosted by Judy Isaacson, Executive Consultant, Vital Now! Medical Marketing and Communications

Seeking subject matter experts (SMEs)! Do you have a case study or a project that you are working on that would give our listeners a better idea of what you do? Contact me if you are interested in spotlighting your company! Sponsorships are also available.

View Event →
Mar
13
11:45 AM11:45

Startup Essentials: Reimbursement Analysis and Planning

The Mansfield Bio-Incubator invites you to a seminar and a networking event

Wednesday, March 13, 2019

Startup Essentials: Reimbursement Analysis and Planning

11:45 am- 1:15 pm

at the Mansfield Bio-Incubator
241 Francis Avenue
Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

 

Description: 

A clear-eyed understanding of the reimbursement landscape is essential to any life science startup’s ability to effectively pursue financing, product development and commercialization. A fully integrated clinical, regulatory and reimbursement plan, responsive to the obstacles and opportunities presented by a rapidly evolving healthcare reimbursement system, can optimize resource utilization and time to revenue and can dramatically change the odds of success.

Join Ed Berger, Principal and Founder of reimbursement consultancy Larchmont Strategic Advisors, for an exploration of the fundamental elements of the reimbursement landscape and practical guidance on how and when to address reimbursement strategy issues for your diagnostic, therapeutic or medtech innovation.

If you want to become a successful life science entrepreneur, it is essential to learn early on how the key stakeholders are going to pay for your product, no matter how great it is.

Who should attend: Early-stage entrepreneurs in life sciences.

Speaker Biography:

Edward E. Berger, Ph.D.
Policy, Reimbursement and Strategy Counsel for the Life Sciences

berger.jpg

A senior healthcare executive with more than 30 years of experience in life science and medical technology reimbursement analysis, planning and advocacy, Ed Berger founded Larchmont Strategic Advisors in 2005 to help early stage companies deal effectively with the strategic challenges and opportunities posed by the rapidly evolving healthcare regulatory and policy environment. Building upon the knowledge and experience gained as a member of the management teams of such companies as Fresenius Medical Care, Thermo Cardiosystems, and ABIOMED, Dr. Berger has provided reimbursement analysis and strategy development consultation to a variety of clients developing new technologies in fields including mechanical circulatory support, orthopedics, neural monitoring and neuromodulation, gastrointestinal surgery, severe pulmonary dysfunction, nuclear medicine, diagnostic imaging, clinical laboratory testing, and personalized medicine. In addition to reimbursement-related services and public policy analysis and advocacy, his areas of expertise include media relations, investor relations, research ethics and patient protection, and corporate compliance programs.


View Event →
Nov
13
11:45 AM11:45

MedMates After Hours: Finding Funding for Your Business.

DESCRIPTION

Join us for this interactive dialogue with experts from Cherrystone Angel Group, the Slater Fund and Medley Genomics about how to be “venture ready.” Our speakers will focus on how to research and network with investors, develop your pitch and position your company for success. They will also share stories of entrepreneurial challenges, surprises, disappointments, tenacity and triumph.

Agenda:

11:45 am – 12:15 pm Registration and networking

12:15-12:25 pm Welcome and Introductions

12:25-12:45 pm Panel presentation

12:45-1:00 pm Audience/Speaker Q&A

1:00-1:15 pm Final networking with participants and presenting speakers

At our Bio-Incubator & MedMates event, you will have the chance to network with the panelists and other meeting attendees, both before the start of the meeting and at the end.

View Event →
Oct
3
12:00 PM12:00

Lunch & Learn: Quality by Design (PD & Mfg).

DESCRIPTION

Boston Institute of Biotechnology invites you to join a Lunch and Learn at the Mansfield Bio-Incubator on Wednesday, October 3rd 12:00pm-1:30pm. Don Ornek PhD and W. Roy Lin PhD will be speaking about the importance of Quality by Design for Biologics. This session will include useful information including process development, manufacturing, and the importance of process characterization.

View Event →
Jun
13
11:30 AM11:30

SBIR/STTR Accounting For Your Startup: What You NEED To Know!

The Mansfield Bio-Incubator invites you to a Lunch and Learn Event on

Wednesday, June 13, 2018

SBIR/STTR Accounting For Your Startup: What You NEED To Know!

11:30 am - 1:00 pm

at the Mansfield Bio-Incubator
241 Francis Avenue
Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

Lunch will be served. 

Program:

Your small business, understanding and preparing your accounting for recordkeeping and reporting are imperative. Realizing that every small business, SBIR awardee or not, generates a wealth of information, this event will help pre-award and awardees see beyond the numbers and shed light on useful data to provide guidance in making effective business decisions ranging from general strategy to development initiatives.

Speaker: 

George G. Moker, CPA
Moker CPA, A Division of Ambrosi Donahue Congdon
Director of Entrepreneurship Programs at Suffolk University - Boston

Speaker Biography:

George is a certified public accountant (CPA) with more than 25 years in public accounting and commercial business. From his experience in helping awardees from all agencies, he has developed training manuals, workshops and seminars in the recordkeeping and reporting compliance areas of government contracting. George earned a master's degree in business administration (MBA) from Suffolk University where he currently serves as Director of Entrepreneurship Programs as well as being a member of the entrepreneurship faculty. George served in senior management positions in the private sector, including roles as Chief Financial Officer and Vice President of Operations in an aerospace support company that provided metrology products and services to the Department of Defense and NASA. George has successfully assisted multiple companies in commercializing and growing their operations. One of his most notable success stories came when assisting his client SmartCells, Inc. as they were acquired by Merck & Company, Inc. for over $500 million. George continues to work with start-ups of various sizes and in various industries.

Who Should Attend

Anyone interested in receiving an SBIR/STTR award, or has received an award and looking down the road to commercialization.

Key Takeaways

  • How to have an adequate accounting system under SBIR/STTR requirements

  • An understanding of the grant requirements

  • How to record labor distribution and timekeeping

  • What indirect rates are

  • How to pass a government agency audit

 

View Event →
Mar
7
6:00 PM18:00

Using Quality Tools from Ideation to Development

Using Quality Tools from Ideation to Development
Wednesday, March 7, 2017
6-9pm
241 Francis Ave, Mansfield, MA

 

Directions: http://bit.ly/2y4EZe9

 

Presented by Amy L Lachapelle and Bill Hackett, QBD Strategies LLC

The value stream that moves biologics and pharmaceuticals from product ideation to product development and eventually to market can benefit from tools known to quality professionals for decades.  Attendees will identify and apply the seven basic quality tools and perform activities that will enable them to apply the quality tools to their own professional endeavours. This will ensure better data integrity, communication, and a smoother flow between process steps in product development leading to commercialization.

The discussion and activities will focus on utilizing a process approach in R&D with a focus on:

  • Strategies to align research with product development
  • The seven basic quality tools
  • Brainstorming for product development
  • Flow charts and your Target Product Profile
  • Measures and metrics to ensure successful progress

This is intended to be a highly interactive session in which we will brainstorm a new product then map a development process that will be a first iteration of the target product profile and your product development strategy. Attendees will learn about approaches to prioritizing research and projects based on need and risk. There will be discussions on identifying appropriate process inputs, measuring process outputs, and monitoring these against the product development strategy to assess progress and success.

View Event →
Oct
18
10:30 AM10:30

Mansfield Bio-Incubator's grand opening.

Mansfield BIO-Incubator Grand Opening

Wednesday, October 18, 2017, at 10:30 am

241 Francis Avenue

Mansfield, MA 02048

 

Come join us as we celebrate the grand opening of southern New England’s newest life sciences incubator!

10:30 am:     Registration, Networking, and Refreshments

11:00 am:     Welcome

Russ Yukhananov, Ph.D., Founder and President, Mansfield BIO-Incubator

Alexander Margulis, Ph.D., Chief Operating Officer, Mansfield BIO-Incubator

Marie Leary, Head of The Sage School

Kara Griffin, Executive Director, Tri-Town Chamber of Commerce

Robert K. Coughlin, President & CEO, Massachusetts Biotechnology Council

Fred Jay Barrows, member of the Massachusetts House of Representatives, 1st Bristol District

11:30 am      Keynote Speaker:

Jay Ash, Secretary, Executive Office of Housing and Economic Development for the Commonwealth of Massachusetts

12:00 pm      Ribbon-cutting, continued networking and celebrating, and facility tours

 4:00 pm       Conclusion

 

We invite you to register using the link below.

https://www.eventbrite.com/e/mansfield-bio-incubator-grand-opening-tickets-37768078339

View Event →
Jul
25
11:00 AM11:00

Customer-Driven Innovation: Exit the Vicious Circle of Failures

THE MANSFIELD BIO-INCUBATOR

Presents

Customer-Driven Innovation: Exit the Vicious Circle of Failures

So, you think you got a great product or technology?

BUT:

  • Investors are not impressed

  • Potential customers are not buying it

  • Development is not feasible or cost-prohibitive

 Learn how to avoid these pitfalls, right from the start!

Join us for the seminar and networking at the newly-opened Mansfield Bio-Incubator on July 25, 2017.

Directions and Parking: http://bit.ly/2sad3m9  Ample parking across from the entrance.

Program Description:

Moderator: 

Brian Shoemaker, PhD, Principal Consultant, ShoeBar Associates

Brian Shoemaker consults for healthcare products companies in computer system validation, software quality assurance, and electronic records and signatures. He has conducted validation both on product software and on internal software, developed software quality systems, audited software quality processes (including agile methodology), and evaluated 21 CFR Part 11 compliance. He has had clients in clinical diagnostics, medical device engineering, medical imaging, medical-device fabrics manufacturing, contract lyophilization, clinical trial software, dental prosthetics, and bone-repair implants. He has worked with companies in Germany and Switzerland as well as the U.S.

Previous to founding ShoeBar Associates, Brian had quality roles at PPD Informatics, Doxis, Inc., and Behring Diagnostics, Inc. Brian earned his Ph.D. in chemistry from the University of Illinois; he has achieved the ASQ Software Quality Engineer certification.

Panelists:

Jeffrey Thumm, President, Duke Devices, LLC

Mr. Thumm is an engineer, entrepreneur, and businessman with over 40 years of experience in new product development and in driving early-stage businesses.  Most of his work has been in medical devices, medical equipment, and chemical sensing and controls for chemical processing.  Mr. Thumm holds BSEE and MBA degrees and has seven patents granted in communications, non-linear sensors, and chemical processing. He is the inventor and patent holder for hydraulically-driven, intense-energy, in-line chemical mixer-reactors and for continuous-energy, particle-reduction processors. 

Through his career, Mr. Thumm has worked with over 30 early stage companies and formed three technology-based companies.  In collaboration with research doctors, PhD chemists and industrial R&D, Mr. Thumm's companies have developed instrumentation solutions for chemical sensing platforms, microfluidic-slide HIV detectors, and microfluidic disks for combinatorial chemistry.  Mr. Thumm's current work includes running a small team in developing a wireless sensor, data-to-cloud solution for remote applications such as pharma processing, agricultural and oil & gas. 

Sophie Chapelle, Managing Director, Golden Seeds

Ms. Chapelle currently works with two Angel Investment Networks: Golden Seeds, investing in women-lead businesses; and 37Angels, a women-only investment group; to review and select for-profit companies for seed investment. In addition, she is a Mentor at the MIT Enterprise Forum, Member of the Board for the National Biomedical Research Foundation (NBMRF) and as Strategic Advisor to Bentley College’s Center for Integration of Science and Industry (CISI). Ms. Chapelle leverages her 20+ years of experience in the business and operations of biopharmaceutical R&D with an academic educational background in business, finance, and operations from Columbia University and in chemical engineering and pharmacology from University of Brussels, Belgium (ULB) and Lille (France). Her credentials are rooted in 23+ years in roles of growing responsibilities in sales & marketing, strategy, financial, operations and people management in large companies such as Pfizer and UCB as well as several smaller organizations.

Richard C. Tharin, RAC, Tharin, Founder, The Cerneos Group, LLC

Mr. Tharin is a Biomedical Scientist and Regulatory Affairs Professional with over 30 years of experience in product development for biotech and medical device products.   His therapeutic experience includes vaccine and diagnostic development, oncology and infectious diseases.  As a scientist and regulatory professional, he has managed the transitions of many firms from start-up to clinical trial and production phases.   His work covers international business and product launches in the US, Latin America, Europe and Asia.  He holds a Bachelor’s Degree in Biology and a Master of Science Degree in Regulatory Affairs. He has developed a consulting firm dedicated to providing resources needed for developing firms from startup to commercialization phases. 

Mr. Tharin’s experience includes being a faculty member in regulatory affairs training programs, development of on-line courses.  He supports startup clients as a mentor in business incubators and accelerator programs.  Mr. Tharin’s current work includes the development of teams to make biologic, tissue culture and electromechanical device products.  As a trainer, he supports local STEM education initiatives at the State and Global level.  He is the founder in his current business, The Cerneos Group, LLC.

What Will You Learn?

Attendees will learn what questions they need to address, ideally before embarking on the product development, or if they hit a stumbling block along the way. In addition, the goal of the panel discussion is to help service providers such as law firms, CRO/CMOs, engineering firms, etc., on how to become not just service providers but also more effective partners and mentors to shorten the timelines and use the resources more efficiently, or in some cases when to "pull the plug" before it is too late.

Who Should Attend?

Life science (biotech, pharma, medical device) entrepreneurs, academic faculty or students/postdocs, scientists from large biotech/pharma/medical devices who would like to commercialize their discoveries.

For tickets and more information, please click here:

http://bit.ly/2syvi7f

View Event →